Regdanvimab

Regdanvimab

Common

Rarity: Common

The most frequent rarity: most Wikipedia articles become Commons.

Rarity follows how well known the article is: its views on the French and English Wikipedia over a year, and the number of languages it exists in.

At a glance

Class
Invention
Domain
Science and technology
Knowledge cost
1
In collections
Nobody has pulled it yet.

What Wikipedia says

Regdanvimab, sold under the brand name Regkirona, is a human monoclonal antibody used for the treatment of COVID-19. The antibody is directed against the spike protein of SARS-CoV-2. It is developed by Celltrion. The medicine is given by infusion (drip) into a vein.

Excerpt from the Wikipedia article “Regdanvimab”, under the CC BY-SA 4.0 license. Read the article on Wikipedia

Open free boosters and add Regdanvimab to your collection.

Play for free

Related cards